Rocket Pharmaceuticals CFO Aaron Ondrey Resigns; Martin Wilson Appointed Interim CFO Effective September 8
Benzinga Newsdesk 1 year ago
NewsManagement
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.On August 20, 2025, Aaron Ondrey resigned as Chief Financial Officer
| Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers. |
On August 20, 2025, Aaron Ondrey resigned as Chief Financial Officer of Rocket Pharmaceuticals, Inc. (the "Company"), effective September 5, 2025, to pursue other opportunities.
On August 25, 2025, Martin Wilson, the Company's General Counsel and Chief Corporate Officer and the Company's Corporate Secretary, was appointed as the Company's interim Principal Financial Officer, effective September 8, 2025.